Researchers have discovered a type of "molecular glue" that can be used to inhibit certain pathological protein interactions.

To achieve that kind of control, Choudhary and his colleagues added a special response element to the Cas9 enzyme and introduced a drug called pomalidomide, which acts as a molecular glue to bring ...

Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. Biomarker-positive patients were rarer than expected in some tumor types ...

the latest techniques for molecular glue drug discovery, and their application in the treatment of diseases. This ACS Webinar is moderated by Angela Zhou, Information Scientist at CAS and is ...

In March 2025, Magnet Biomedicine formed a partnership and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapeutics. In January 2025 ...

Monte Rosa Therapeutics has seen good news for one of its molecular glue degradation candidates and bad news for another with one immunotherapy study showing promising results whilst another in ...

The device, made by a team from the University of Cambridge, combines tiny semiconductor nanocrystals called quantum dots and gold nanoparticles using molecular glue called cucurbituril (CB).